Given CCL5’s role as an immune and cancer cell survival factor, we hypothesized that CCL5 secreted by ZIKV-infected hBMECs could similarly promote prosurvival CCR3/CCR5 signaling responses that permit ZIKV to persistently infect hBMECs. This evidence concerns the gene CCR5 and cancer.